Search Results

CRM Salesforce, Inc. - Fundamental Analysis

NEUTRAL
Sign in to save Save this symbol to a watchlist or track a position.
CRM Stock | Fundamental Analysis & Investment Insights
NASDAQ Technology Software - Application
Current Price Live
$227.11
Analyst Target
$329.65
+45.1% Upside
52W High
$367.09
52W Low
$221.96

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 17, 2026
Market cap
$216.21B
P/E
30.28
ROE
12.2%
Profit margin
17.9%
Debt/Equity
0.19
Dividend yield
0.71%

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
75%
Analysis Accuracy
CRM exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating solid profitability, leverage, and operating efficiency. Despite this, the stock trades above its Graham Number of $103.69 at $227.11, reflecting a significant premium driven by growth expectations, though forward P/E of 17.32 suggests some valuation normalization. Strong earnings growth (38.6% YoY) and consistent estimate beats support future optimism, but weak technical trend (0/100) and negative insider activity raise near-term caution. Relative to peers, CRM shows moderate revenue growth but lags in recent price performance with a -28.6% 1-year return.

Key Strengths

High Piotroski F-Score of 7/9 indicates strong financial health and operational efficiency
Exceptional profitability with gross margin of 77.73%, operating margin of 23.86%, and profit margin of 17.91%
Strong year-over-year earnings growth of 38.6% and consistent quarterly earnings beats (22 of last 25 quarters)
Low leverage with Debt/Equity ratio of 0.19, indicating conservative capital structure
High insider sentiment score of 60/100 despite recent selling, suggesting underlying confidence

Key Risks

Current Ratio of 0.98 and Quick Ratio of 0.79 indicate potential short-term liquidity pressure
Missing Altman Z-Score prevents definitive distress risk assessment, creating analytical gap
Negative technical trend (0/100) signals strong bearish momentum in price action
Insider selling of $31.61M in last 6 months suggests caution among executives
Valuation premium: current price ($227.11) is more than double the Graham defensive value ($103.69)
AI Fair Value Estimate
Based on comprehensive analysis
$221.25
-2.6% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
65
Strong
Value
50
Future
78
Past
70
Health
85
Dividend
40
AI Verdict
Moderately bullish on fundamentals, tempered by valuation and technical concerns
Key drivers: Strong Piotroski F-Score, Robust earnings growth, Premium valuation, Bearish technical trend, Insider selling
Confidence
80%
Value
50/100

Ref P/E, PEG, Graham Number

Positives
  • Forward P/E of 17.32 is reasonable for a growth company
  • Intrinsic Value (Formula) of $221.25 is close to current price
Watchpoints
  • Current P/E of 30.28 is high
  • Price/Sales of 5.36 is elevated
  • Current price 119% above Graham Number
Future
78/100

Ref Growth rates

Positives
  • Revenue growth of 8.60% YoY
  • Earnings growth of 38.60% YoY
  • Q/Q earnings growth of 36.60%
  • Analyst target price of $329.65 implies 45% upside
Watchpoints
No urgent risks highlighted.
Past
70/100

Ref Historical trends

Positives
  • 22 of last 25 quarters beat EPS estimates
  • Average earnings surprise of 7.76% over last 4 quarters
  • Consistent upward trajectory in EPS
Watchpoints
  • 1-year price return of -28.6% underperforms sector
Health
85/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 7/9 indicates strong financial health
  • ROE of 12.18% and ROA of 5.95% show efficient use of equity and assets
  • Debt/Equity of 0.19 reflects low financial risk
Watchpoints
  • Current Ratio of 0.98 and Quick Ratio of 0.79 suggest near-term liquidity risk
Dividend
40/100

Ref Yield, Payout

Positives
  • Payout ratio of 22.00% is sustainable
  • Dividend yield of 0.71% provides minor income
Watchpoints
  • Dividend Strength score of 25/100 indicates weak dividend profile
  • No 5-year average yield data suggests limited history or consistency

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$227.11
Analyst Target
$329.65
Upside/Downside
+45.1%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CRM and closest competitors.

Updated 2026-01-16
Company 5Y 3Y 1Y 6M 1M 1W
CRM
Salesforce, Inc.
Primary
+6.0% +54.8% -28.6% -13.2% -11.9% -12.6%
INTC
Intel Corporation
Peer
-10.4% +64.5% +138.7% +103.3% +30.3% +3.1%
KLAC
KLA Corporation
Peer
+426.8% +288.2% +111.6% +69.0% +33.8% +12.0%
APH
Amphenol Corporation
Peer
+376.2% +290.2% +93.7% +44.2% +9.5% -2.2%
ACN
Accenture plc
Peer
+19.4% +6.6% -21.9% -0.7% +4.1% -1.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
30.28
Forward P/E
17.32
PEG Ratio
N/A
P/B Ratio
3.56
P/S Ratio
5.36
EV/Revenue
5.29
EV/EBITDA
18.06
Market Cap
$216.21B

Profitability

Profit margins and return metrics

Profit Margin 17.91%
Operating Margin 23.86%
Gross Margin 77.73%
ROE 12.18%
ROA 5.95%

Growth

Revenue and earnings growth rates

Revenue Growth +8.6%
Earnings Growth +38.6%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +36.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.19
Low debt
Current Ratio
0.98
Weak
Quick Ratio
0.79
Poor
Cash/Share
$12.08

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-25
$N/A
2025-12-03
$3.25
+13.6% surprise
2025-09-03
$1.96
+8.4% surprise
2025-05-28
$2.58
+1.3% surprise

Technology Sector Comparison

Comparing CRM against 149 companies in the Technology sector (10 bullish, 66 neutral, 73 bearish)
P/E Ratio
30.28
This Stock
vs
90.97
Sector Avg
-66.7% (Discount)
Return on Equity (ROE)
12.18%
This Stock
vs
-8.13%
Sector Avg
-249.9% (Below Avg)
Profit Margin
17.91%
This Stock
vs
-7.75%
Sector Avg
-331.0% (Weaker)
Debt to Equity
0.19
This Stock
vs
0.76
Sector Avg
-74.6% (Less Debt)
Revenue Growth
8.6%
This Stock
vs
56.87%
Sector Avg
-84.9% (Slower)
Current Ratio
0.98
This Stock
vs
3.33
Sector Avg
-70.5% (Weaker)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
CRM
Salesforce, Inc.
NEUTRAL $216.21B 30.28 12.2% 17.9% $227.11
INTC
Intel Corporation
NEUTRAL $224.0B 782.67 0.2% 0.4% $46.96
KLAC
KLA Corporation
NEUTRAL $206.46B 49.26 99.2% 33.8% $1567.82
APH
Amphenol Corporation
NEUTRAL $184.82B 50.84 34.8% 18.2% $150.99
ACN
Accenture plc
NEUTRAL $174.3B 23.58 25.0% 10.8% $281.07

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2026-01-13 BENIOFF MARC RUSSELL Chief Executive Officer Option Exercise 1 $215
2025-12-22 MILANO MIGUEL President Stock Award 1,016 -
2025-12-22 NILES SABASTIAN President Stock Award 1,016 -
2025-12-22 TALLAPRAGADA SRINIVAS D. Officer Stock Award 2,525 -
2025-12-22 REDDY SUNDEEP G Officer Stock Award 574 -
2025-12-22 HARRIS G PARKER Officer and Director Stock Award 2,271 -
2025-12-17 KIRK DAVID BLAIR Director Purchase 1,936 $500,722
2025-12-05 MORFIT G MASON Director and Beneficial Owner of more than 10% of a Class of Security Purchase 96,000 $25,015,680
2025-12-02 HARRIS G PARKER Officer and Director Sale 134,662 $31,605,031
2025-12-02 HARRIS G PARKER Officer and Director Option Exercise 134,662 $21,747,913
2025-11-21 MILANO MIGUEL President Stock Award 1,662 -
2025-11-21 KIRK DAVID BLAIR Director Stock Award 424 -
2025-11-21 NILES SABASTIAN President Stock Award 1,662 -
2025-11-21 ALBER LAURA Director Stock Award 274 -
2025-11-21 WEBB MAYNARD GEORGE JR Director Stock Award 274 -
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
53 analysts
Barclays
2026-01-12
Maintains
Overweight Overweight
RBC Capital
2026-01-05
Maintains
Sector Perform Sector Perform
BTIG
2025-12-17
init
Buy
Morgan Stanley
2025-12-09
Maintains
Overweight Overweight
Citigroup
2025-12-08
Maintains
Neutral Neutral
DA Davidson
2025-12-05
Maintains
Neutral Neutral
Truist Securities
2025-12-04
Maintains
Buy Buy
Macquarie
2025-12-04
Maintains
Neutral Neutral
Northland Capital Markets
2025-12-04
Maintains
Market Perform Market Perform
Deutsche Bank
2025-12-04
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning CRM from our newsroom.

Newest → oldest
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile